1W Return
1M Return
6M Return
1Y Return
3Y Return
Open
Prev. Close
Total Traded Value
Market Cap (in crs)
Face Value
Turnover (in lacs)
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
3028.59 Cr | 3349.11 Cr | 2814.64 Cr | 3255.06 Cr | 3203.84 Cr |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
12886.42 Cr | 11975.28 Cr | 11281.84 Cr | 9871.89 Cr | 8989.93 Cr |
Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
417.28 Cr | 494.55 Cr | 341.62 Cr | 506.84 Cr | 506.55 Cr |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
1811.82 Cr | 1702.96 Cr | 1744.1 Cr | 1695.96 Cr | 1447.93 Cr |
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 2530667 Rs | 3712201 Rs |
Week Rs | 1498602 Rs | 2442260 Rs |
Month Rs | 1622520 Rs | 2694691 Rs |
Company | Market Price | Market Cap | 52W Low | 52W High |
---|---|---|---|---|
74819.17 | 2354 | 3890 | ||
30681.53 | 5956.05 | 10699 | ||
109420.92 | 1025.8 | 1541.85 | ||
548371.1 | 2172.05 | 3035 | ||
81334.98 | 486.3 | 719.85 | ||
49063.59 | 15001 | 17745 |
Dabur India Ltd. stands as one of the leading FMCG (Fast-Moving Consumer Goods) companies in India and is recognized globally as a pioneer in Ayurveda and herbal products. With a diversified portfolio of over 250 herbal and Ayurvedic products, Dabur serves a wide range of consumer needs in categories such as Hair Care, Oral Care, Health Care, Skin Care, Home Care, and Foods. Among its flagship brands are Dabur, the master brand for healthcare products; Vatika, a premium personal care line; Hajmola, known for its digestives; Real, offering fruit juices and beverages; and Fem, catering to fairness and skincare. The company’s focus on Ayurveda and natural products sets it apart in both domestic and international markets.
Dabur operates through three Strategic Business Units (SBUs): the Consumer Care Division (CCD), the International Business Division (IBD), and the Consumer Health Division (CHD). The CCD focuses on healthcare, personal care, home care, and foods. The CHD is dedicated to Ayurvedic and health-related products, while the IBD oversees the company’s international ventures, featuring iconic brands such as Dabur Amla and Vatika. These divisions reflect Dabur’s commitment to leveraging traditional knowledge and modern technology to meet evolving consumer preferences.
Dabur’s manufacturing capabilities are extensive, with 20 state-of-the-art facilities globally, including 12 in India. Notable Indian locations include Baddi (Himachal Pradesh), Pantnagar (Uttarakhand), Sahibabad (Uttar Pradesh), and Newai (Rajasthan), among others. Internationally, the company operates facilities in Dubai, Sharjah, Egypt, Nigeria, Nepal, and Bangladesh, showcasing its global footprint. This robust infrastructure ensures high-quality production to meet domestic and international demand.
Dabur boasts a vast distribution network, reaching over six million retail outlets across urban and rural India. Its products have a global presence, available in more than 120 countries. Notably, the company has a strong foothold in regions like the Middle East, SAARC nations, Africa, the US, Europe, and Russia. Dabur’s international business contributes over 30% to its total revenue, underscoring its significance in the company’s growth strategy.
Dabur India Ltd. was established on September 16, 1975, initially focusing on manufacturing edible industrial guar gum powder. By 1978, the company introduced Hajmola, an Ayurvedic digestive tablet, which became a household name. The 1980s marked a significant expansion with the launch of pharmaceutical medicines and the establishment of Dabur Research Foundation. In 1989, the company innovatively transformed its digestive product into a children-friendly offering with Hajmola Candy.
The 1990s were transformative, with the launch of Real Fruit Juice in 1996, marking Dabur’s entry into the foods segment. This was followed by the establishment of a modern manufacturing unit in Baddi, catering to products like Chyawanprash and Ayurvedic oils. By 1998, the Burman family handed over the company’s management to professionals, marking a shift towards corporate governance and strategic growth.
The 2000s witnessed Dabur’s diversification into various segments and geographies. In 2005, it acquired Balsara’s Hygiene and Home Products, enhancing its oral and home care portfolio. The following year, Dabur entered the Pakistani market with a subsidiary and later merged Dabur Foods Ltd. into its operations, streamlining its food business. The acquisition of Fem Care Pharma Ltd. in 2010 expanded Dabur’s presence in skincare.
In the international arena, Dabur acquired Hobi Kozmetik Group in Turkey and Namaste Laboratories LLC in the US in 2011, gaining access to ethnic hair care markets in Africa, the US, and Europe. These acquisitions bolstered Dabur’s global footprint and product diversity.
Dabur has consistently embraced innovation to meet consumer needs. The launch of flavoured Chyawanprash, online shopping portals, and mobile honey-testing labs are testaments to its forward-thinking approach. Its collaboration with Amazon in 2017 to expand its reach in the US and other global markets highlights its commitment to leveraging e-commerce for growth. These initiatives have also played a role in enhancing consumer awareness of products like Dabur India Share Price, which reflects the company's strong market performance.
Dabur’s roots in Ayurveda have remained integral to its identity. Over the years, the company has introduced numerous Ayurvedic formulations, such as Ayush64 for malaria and Ayush82 for diabetes. During the COVID-19 pandemic, Dabur expanded its range of immunity-boosting products, including Giloy Churna and Tulsi drops. Its entry into the Siddha medicine market with products like Kabasura Kudineer further reinforces its dedication to traditional health systems.
In recent years, Dabur has focused on its power brands, including Dabur Chyawanprash, Dabur Honey, and Real Juices. It has also introduced new products, such as Dabur Cool King Hair Oil and herbal toothpaste variants. In 2023, the acquisition of a majority stake in Badshah Masala Pvt. Ltd. marked its entry into the spices segment, broadening its FMCG portfolio. The company’s increasing emphasis on sustainable and eco-friendly practices, such as its Tezpur manufacturing facility, reflects its commitment to environmental responsibility.
Dabur India Ltd. has evolved from a family-run business to a globally recognized FMCG powerhouse with a diverse portfolio and a strong emphasis on Ayurveda and natural products. Its extensive distribution network, innovative product offerings, and strategic acquisitions have solidified its position in the market. As the company continues to grow, it remains a trusted name among consumers and investors alike, with its Dabur India Share Price reflecting its consistent performance and future potential.
Dabur India Ltd shares are currently priced at 502.55 on NSE and 501.9 on BSE as of 12/19/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.
The past 1-year return of Dabur India Ltd [DABUR] share was -6.05. The Dabur India Ltd [DABUR] share hit a 1-year low of Rs. 489.2 and a 1-year high of Rs. 672.
The market cap of Dabur India Ltd is Rs. 89067.69 Cr. as of 12/19/2024 12:00:00 AM.
The PE ratios of Dabur India Ltd is 61.51 as of 12/19/2024 12:00:00 AM.
The PB ratios of Dabur India Ltd is 12.31 as of 12/19/2024 12:00:00 AM
The Mutual Fund Shareholding was 6.21% at the end of 12/19/2024 12:00:00 AM.
You can easily buy Dabur India Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.